Article
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.
Journal of neuro-oncology - 1 Feb 2015
Di Stefano Anna Luisa, Labussiere Marianne, Lombardi Giuseppe, Eoli Marica, Bianchessi Donata, Pasqualetti Francesco, Farina Patrizia, Cuzzubbo Stefania, Gallego-Perez-Larraya Jaime, Boisselier Blandine, Ducray Francois, Cheneau Caroline, Moglia Arrigo, Finocchiaro Gaetano, Marie Yannick, Rahimian Amithys, Hoang-Xuan Khe, Delattre Jean Yves, Mokhtari Karima, Sanson Marc
Abstract excerpt
Although anti-VEGF therapy is widely used in high-grade gliomas, no predictor of response or toxicity has been reported yet. We investigated here the association of the functional single nucleotide polymorphism (SNP) rs2010963, located in the 5' untranslated terminal region of the VEGFA gene, with survival, response to bevacizumab (BVZ) and vascular toxicity. The rs2010963 was genotyped by Taqman assay in blood...
Read the complete abstract on PubMed